Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Eye Res ; 168: 49-56, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29326066

RESUMEN

In the present study, therapeutic effect of topically applied everolimus (EV)-loaded methoxy-poly(ethylene-glycol)-hexyl substituted poly (lactic acid) (mPEGhexPLA) nanocarriers on experimental autoimmune uveoretinitis (EAU) were investigated. EAU was induced in B10.RIII mice via immunization with human interphotoreceptor retinoid-binding protein peptide 161-180 (hIRBPp161-180) in complete Freund's adjuvant. Everolimus-loaded mPEGhexPLA (EV/mPEGhexPLA) nanocarriers were prepared by using a solvent evaporation method. On days 12-21 postimmunization (p.i.), the right eyes were treated five times daily either with 10 µl of 0.5% everolimus formulation or PBS (control). The EAU score of the eyes was determined histologically. On day 21 p.i., the peripheral immune responses were measured in serum, cervical lymph nodes (LN), and spleens via hIRBPp161-180-specific serum antibodies, cytokine secretion (ELISA), lymphocyte proliferation, and FoxP3+ regulatory T cells (Treg; flow cytometry). Compared to the PBS-treated mice, unilateral topical everolimus treatment significantly reduced EAU severity in both eyes (p < .05). The treatment reduced the antigen (Ag)-specific hIRBPp161-180-induced proliferation (p < .05), IL-2, IL-17, and IFN-γ secretion from cells isolated from the left and right cervical LN (p < .05). Under everolimus treatment, IL-10 secretion and CD4+CD25+FoxP3+ Treg frequency from cervical LN were enhanced. The proliferative response and cytokine secretion as well as the frequency of splenic Treg were almost unchanged. Topical administration of an everolimus formulation improved EAU in both eyes. The effect might also be related to systemic immunosuppressive effects, as several systemic cellular immune responses were influenced.


Asunto(s)
Enfermedades Autoinmunes/tratamiento farmacológico , Sistemas de Liberación de Medicamentos/métodos , Everolimus/administración & dosificación , Inmunosupresores/administración & dosificación , Nanocápsulas/uso terapéutico , Retinitis/tratamiento farmacológico , Animales , Autoanticuerpos/sangre , Proliferación Celular/efectos de los fármacos , Citocinas/metabolismo , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Interferón gamma/metabolismo , Activación de Linfocitos/efectos de los fármacos , Ratones , Retinitis/inmunología , Bazo/metabolismo
2.
J Control Release ; 275: 32-39, 2018 04 10.
Artículo en Inglés | MEDLINE | ID: mdl-28774843

RESUMEN

We have developed a self-assembling polymeric nanocarrier to deliver the potent immunosuppressive drug Cyclosporine A (CsA) to inflammatory lesions in ulcerative colitis (UC) patients. Our nanocarrier has a high drug loading capacity and efficiently targets its CsA payload to the diseased tissue after local administration. Tissue drug levels were several orders of magnitude higher in animals suffering from a trinitrobenzene-sulfonic acid (TNBS) - induced colitis, compared to healthy control animals; no drug was detectable in the plasma, underlining the localized delivery strategy. An efficient reduction in inflammation score was obtained with a CsA dose of 1mg/mL. Therapeutic efficacy was comparable to 5-aminosalicylic acid (5-ASA), the positive control treatment in the TNBS-induced colitis model. Repetitive treatment of healthy animals with CsA nanocarriers for seven days was well tolerated with no alterations in colon histology.


Asunto(s)
Antiinflamatorios/administración & dosificación , Colitis Ulcerosa/tratamiento farmacológico , Ciclosporina/administración & dosificación , Portadores de Fármacos/administración & dosificación , Inmunosupresores/administración & dosificación , Nanopartículas/administración & dosificación , Animales , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/patología , Colon/efectos de los fármacos , Colon/patología , Masculino , Ratones Endogámicos C57BL , Polímeros/administración & dosificación , Ácido Trinitrobencenosulfónico
3.
Sci Rep ; 7(1): 4053, 2017 06 22.
Artículo en Inglés | MEDLINE | ID: mdl-28642589

RESUMEN

Despite the highly economic value of tea in Africa, its genetic and geographic origins remain largely unexplored. Here we address this by collecting 439 samples across 11 countries in Africa and Asia to investigate the origin and genepool composition of African tea based on 23 nuclear microsatellites loci (nSSRs) and three cpDNA intergenic spacer regions. Our results indicated that the African tea represents a potpourri originating from multiple introductions over time. The nSSR analysis revealed that the majority (79%) of tea accessions collected in Africa belong to Indian Assam tea which have likely originated from India and/or Sri Lanka. The patterns of nSSR variation also showed that Chinese Assam tea is genetically distinct from Indian Assam tea, and has rarely been used in African tea breeding efforts since only 4% of the African tea accessions possessed this genotype. We found a total of 22 cpDNA haplotypes, which grouped into three main geographic clades that were concordant with the distribution of microsatellite genotypes. Several private cpDNA haplotypes were identified in Chinese Assam tea in Southern Yunnan province of China. Therefore Chinese Assam tea will be important for the enrichment of African tea gene pools. Our results is a useful guide in future tea breeding programmes in Africa.


Asunto(s)
Camellia sinensis/genética , Genes de Plantas , Marcadores Genéticos , Semillas/genética , África , Alelos , Teorema de Bayes , Camellia sinensis/clasificación , ADN de Cloroplastos , Variación Genética , Genotipo , Geografía , Repeticiones de Microsatélite , Filogenia , Plastidios/genética
4.
J Ethnopharmacol ; 147(1): 190-203, 2013 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-23473867

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Three species of yews Taxus contorta Griff., Taxus mairei (Lemée & Lév.) S.Y. Hu ex T.S. Liu and Taxus wallichiana Zucc. distributed in the Hindu Kush-Himalayan (HKH) region have been commercially exploited in recent decades to extract an anticancer chemotherapeutic drug 'Taxol'. Additionally, indigenous people of this region are using yews for several other purposes including gastro-intestinal disorders, respiratory problems, skeletal system disorders, and as edible fruit, fodder, fish poison, traditional veterinary medicine, among others. AIM OF THE STUDY: The study was designed to document and evaluate knowledge concerning uses of yews among indigenous communities of Mongol and Caucasian origins. MATERIALS AND METHODS: Ethnobotanical knowledge from 10 major ethnic/caste groups of Mongol and Caucasian origins in the Nepal Himalayas was documented in 2010 and 2011 from 27 sites covering the extant distribution range of the three species of Taxus. A total of 72 key informants (60 men, 12 women), recommended by the majority of people in informal group discussions at each study site, were interviewed to collect information on the importance of yews. RESULTS: This study reports multidimensional uses of yews commonly practiced by different indigenous communities of Nepal and compared those with published uses along the HKH region. The key informants cited a total 45 uses under 21 categories. A greater use diversity and high consensus value for use types were recorded for medicinal uses (gastro-intestinal ailments, cough and cold, skeleto-muscular system problem and others medicinal importance) followed by fruit consumption, household tools, agriculture implements and timber. A decline of yew populations and associated traditional knowledge among the younger generations of indigenous people was found. CONCLUSION: The present study shows a strong agreement of ethnobotanical knowledge on yews between communities of Mongols and Caucasian origins. Our findings further revealed the potential for additional therapeutic applications in yews of the HKH region, besides cancer treatment. To compensate the low yield of 'Taxol', and the fact that three yew species are involved, the reported species-specific curative properties need to be validated scientifically and evaluated clinically. Moreover, initiatives should be taken immediately to stop further degradation of yew populations and the associated indigenous knowledge in the HKH region.


Asunto(s)
Pueblo Asiatico , Etnofarmacología , Conocimientos, Actitudes y Práctica en Salud/etnología , Medicina Tradicional Mongoliana , Preparaciones de Plantas/uso terapéutico , Taxus , Población Blanca , Adulto , Anciano , Anciano de 80 o más Años , Características Culturales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mongolia , Nepal , Fitoterapia , Preparaciones de Plantas/aislamiento & purificación , Plantas Medicinales , Taxus/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA